Peregrine Beats Shareholder Suit Over Lung Cancer Drug
A California federal judge tossed a consolidated class action against Peregrine Pharmaceuticals Inc. on Friday, saying the investor plaintiffs didn't adequately allege that the drugmaker and its executives knowingly lied about...To view the full article, register now.
Already a subscriber? Click here to view full article